Company Comparison
FibroGen vs BioAnalytics Pro
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | FibroGen | BioAnalytics Pro |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | San Francisco, CA | Cambridge |
| Founded | 1993 | — |
| Status | Active | Active |
| Last Funding Stage | IPO | Series A |
| Total Funding | — | $45M |
| Valuation | — | — |
What They Build
FibroGen
Biopharmaceutical company focused on developing therapies for fibrotic diseases, anemia, and cancer through innovative drug discovery.
BioAnalytics Pro
Cambridge-based biotech company developing advanced analytics solutions for life sciences applications.
Key Investors
FibroGen
BioAnalytics Pro
No investors listed.
Sector Overlap
Both FibroGen and BioAnalytics Pro operate in Biotech.
Browse all Biotech companies →Websites
The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.
14-day free trial. No credit card required.